Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Dr. Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Ningxia Center for Disease Control and Prevention | China

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Prof. Dr. Wu Zhonglan's academic journey is marked by excellence and global engagement. Currently pursuing her PhD in Pathogen and Host Immunology, she laid a strong foundation with earlier distinctions that shaped her scientific career. Her selection for the National Scholarship enabled a year of advanced study at the QIMR Berghofer Medical Research Institute in Australia (2017–2018), reflecting both national confidence and international potential in her research acumen.

💼 Professional Endeavors

Prof. Wu serves as Chief of the Virus Section at the CDC and a Postgraduate Supervisor at Ningxia Medical University, underscoring her pivotal role in both research and mentorship. She holds influential appointments across national committees, including:

  •  ➤ Director, National AIDS Prevention and Control Association

  •  ➤ Member, National AIDS Testing Committee

  •  ➤ Member, National Microbial Sequencing Technical Committee

  •  ➤ Member, Ningxia Immunology Society

  •  ➤ Editorial Board Member, Journal of Phenomics

Her leadership spans laboratory diagnostics, public health strategy, and national policy.

🔬 Contributions and Research Focus

Prof. Wu’s scientific contributions are rooted in two major domains:

🦠 Viral Pathogen Research:
She has been at the forefront of utilizing Next-Generation Sequencing (NGS) technology for viral traceability—particularly for COVID-19 and monkeypox. Her innovative development of rapid screening platforms for unexplained pneumonia pathogens has strengthened epidemic preparedness and public health surveillance.

🧬 AIDS Molecular Epidemiology:
Prof. Wu is a key figure in HIV research in China. Her work involves constructing molecular transmission networks, analyzing HIV drug resistance, and refining HIV-RNA and HIV-DNA diagnostic technologies for improved treatment strategies and epidemiological tracing. She has successfully led 8 major research projects funded by the Natural Science Foundation, returnee innovation grants, and key R&D initiatives in Ningxia.

🏆 Accolades and Recognition

Prof. Wu has garnered widespread acclaim, including:

  •  ➤ National Public Health Leading Talent Program (2024)

  •  ➤ “Advanced Worker” of the Autonomous Region (2025)

  •  ➤ Ningxia Young Top Talent Cultivation Program (2017)

Her team’s achievements have been celebrated with:

  •  ➤ Third Prize for Scientific and Technological Progress (2019, 2023)

  •  ➤ Second Prize and two Third Prizes of the Ningxia Medical Science and Technology Awards

🌍 Impact and Influence

Through her pioneering work in pathogen genomics and HIV epidemiology, Prof. Wu has enhanced both regional and national capacities in disease control. Her influence extends into policy-making, health strategy design, and next-generation diagnostics. She is a role model for women in science, especially in traditionally male-dominated public health and molecular virology sectors.

📚 Legacy and Future Contributions

Prof. Wu has authored over 60 high-impact publications, with 14 SCI-indexed papers—one boasting an impact factor of 11.39. More than 10 papers have earned Outstanding Paper Awards in Ningxia, reflecting her consistent excellence in scientific communication. Looking ahead, Prof. Wu is poised to further shape China’s viral disease research landscape through integrative genomics, real-time diagnostics, and transdisciplinary collaborations. Her legacy will be defined not only by her discoveries but by the generations of researchers she continues to inspire.

Publications

📄  Sequencing of One Unique Recombinant CRF85_BC/CRF01_AE Genome and Two Partial Genomes from Ningxia, China

Authors: Li Y, Pei J, Zhu X, Liu Y, Ma X, Yang D, Wu Z
Journal: Viruses
Year: 2025

📄  HIV-1 Drug Resistance and Genetic Transmission Networks Among Patients with Sexually Transmitted HIV in Ningxia, China

Authors: Pei J, Wu Z, Si B, Ma C, Liu Y, Ma X, Kuai W, Zhang Y, Li Y
Journal: Frontiers in Public Health
Year: 2025

📄  Epidemiological and Spatial Analysis of Newly Diagnosed HIV-1/AIDS Patients Before Antiretroviral Therapy in Ningxia from 2020 to 2021

Authors: Liu Y, Ma X, Pei J, Yang D, Li Y, Zhu X, Wu Z
Journal: PLOS ONE
Year: 2025

📄  Epidemiological and Spatiotemporal Analysis of Elderly HIV-1/AIDS Patients in Ningxia, China, from 2018 to 2023

Authors: Wu Z, Liu Y, Ma X, Li Y, Zhu X, Yang D, Pei J, Li Y
Journal: Scientific Reports
Year: 2025

📄  Molecular Epidemiology of Hepatitis C Infections in Ningxia, China: Genotype, Phylogeny and Mutation Analysis

Authors: Wu Z, Cui L, Zhao W, Yang D, Chen H, Wang R, Wang X, Zhang L, He T
Journal: Virology Journal
Year: 2016

Theopista Lotto | Health Professions | Best Research Article Award

Published on by Book of Award

Ms. Theopista Lotto | Health Professions | Best Research Article Award

Ifakara Health Institute | Tanzania

Author Profile

Orcid

🎓 Early Academic Pursuits

Ms. Theopista Lotto embarked on her academic journey with a deep commitment to healthcare and research. She earned her Bachelor of Pharmacy from Muhimbili University, Dar es Salaam, Tanzania (2003-2007), laying a strong foundation in pharmaceutical sciences. Her passion for healthcare monitoring and evaluation led her to pursue an MSc in Health Monitoring and Evaluation at Mzumbe University, Morogoro, Tanzania (2013-2015). Further advancing her expertise, she attained a PhD in Epidemiology and Public Health from Swiss TPH, Switzerland (2021-2023), equipping her with cutting-edge skills in public health research and antimicrobial resistance (AMR) studies.

💼 Professional Endeavors

Ms. Lotto has demonstrated exceptional leadership and expertise in public health, antimicrobial stewardship, and pharmaceutical research through her extensive professional journey. She currently serves as an M&E Advisor for the CDC Project on Sustainable Health System Strengthening at Mzumbe University (2024-Present), where she designs and implements evaluation frameworks and supports national health initiatives. Her role as a Technical Expert and In-Country Consultant for the Commonwealth Pharmacist Association (2023-Present) underscores her influence in antimicrobial stewardship, ensuring that healthcare programs align with Tanzania’s National Action Plan on AMR. Previously, she was a Research Scientist at Ifakara Health Institute (2020-2024), where she led multiple AMR surveillance projects and cross-sectional studies on antimicrobial use. Her earlier career includes impactful roles such as M&E Advisor at Tanzania Institute of Monitoring and Evaluation (2019-2020), DHIS2 Coordinator at Mbeya District Council (2015-2019), and District Pharmacist at Mbeya District Council (2009-2015). These positions highlight her extensive experience in data-driven decision-making, pharmaceutical logistics, and healthcare policy implementation.

🔬 Contributions and Research Focus

Ms. Lotto’s research focuses on antimicrobial resistance, antimicrobial stewardship, public health surveillance, and health system strengthening. She has played a pivotal role in:

  • Designing and leading AMU & AMS projects at Ifakara Health Institute, conducting large-scale community surveys to assess antimicrobial use in Tanzania.
  • Implementing electronic Clinical Decision Support Algorithms (CDSA) to promote antibiotic stewardship and improve pediatric healthcare outcomes.
  • Enhancing health monitoring systems through her expertise in Health Information Systems (DHIS2) and supporting national stakeholders with data-driven decision-making.

Her research has significantly contributed to the development of antimicrobial resistance policies, ensuring that Tanzania aligns with global AMR mitigation strategies.

🏆 Accolades and Recognition

Ms. Lotto’s contributions have earned her recognition as a leading researcher in public health and pharmacy. She has been instrumental in multiple government and international health projects, showcasing her ability to foster cross-sector collaborations with organizations like the CDC, Commonwealth Pharmacist Association, and Ifakara Health Institute. Her technical expertise in antimicrobial stewardship has positioned her as a sought-after consultant in Tanzania’s healthcare system.

🌍 Impact and Influence

Ms. Lotto’s work has had a far-reaching impact on Tanzania’s public health landscape. She has:

  • Strengthened AMR surveillance and antimicrobial stewardship programs at a national level.
  • Improved healthcare monitoring and evaluation frameworks through innovative data collection and analysis.
  • Supported policy formulation and implementation, working closely with government ministries and international health bodies.
  • Provided training and mentorship to healthcare professionals, ensuring sustainable knowledge transfer in pharmaceutical management and public health research.

Her influence extends beyond research; she actively engages policymakers, healthcare practitioners, and academic institutions to drive meaningful change in the fight against AMR.

🔮 Legacy and Future Contributions

As a visionary leader in public health and pharmacy, Ms. Lotto continues to pave the way for stronger healthcare systems in Tanzania. Her future contributions are expected to focus on:

  • Expanding AMR research to include more comprehensive national and regional studies.
  • Developing innovative pharmaceutical management tools to optimize drug distribution and usage.
  • Strengthening international collaborations to combat antimicrobial resistance on a global scale.
  • Training and mentoring the next generation of researchers in epidemiology and public health.

With her unwavering dedication and expertise, Ms. Lotto is set to leave a lasting legacy in global health research and pharmaceutical sciences, ensuring sustainable and evidence-based healthcare practices for generations to come.

 

Publications

📄 Population-Based Prevalence of Antibiotic Residuals in Low, Moderate and High Malaria Endemicity Areas in Tanzania
Author(s): Theopista Lotto, Joanna Gallay, Martin Zuakulu, Beatrice Ternon, Laurent Arthur Decosterd, Alexandra V. Kulinkina, Blaise Genton
Journal: Antibiotics
Year: 2025